Price movement over the last 24 hours
Aurora Cannabis Inc vs Cadence Design Systems Inc — how do they compare? Aurora Cannabis Inc trades at $2.67 (market cap $165.36M), while Cadence Design Systems Inc trades at $372.06 (market cap $102.34B). The key difference: Cadence Design Systems Inc is far larger — about 618.9× Aurora Cannabis Inc's market cap, and Cadence Design Systems Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | CDNS | |
|---|---|---|
Market Cap | $165.36M | $102.34B |
Sector | Health | Technology |
52-Week High | $6.23 | $416.39 |
52-Week Low | $2.67 | $265.66 |
Enterprise Value | $99.82M | $104.02B |
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
Cadence Design Systems (CDNS) trades at $371.06, down 0.56% on the day, with strong analyst support showing 84% buy ratings and a $395.88 consensus price target. The stock demonstrates robust fundamentals with consistent earnings beats, 86% gross margins, and 21% net income margins. Recent technical analysis shows neutral momentum with support at $370 and resistance at $380. The company benefits from AI-driven semiconductor design demand and recently announced expanded collaboration with Intel Foundry.
CDNS presents a compelling growth story with strong profitability and market positioning in EDA software. The primary investment thesis centers on sustained AI-driven demand for chip design tools, though elevated valuation multiples (P/E 87.6) require continued execution. Key risks include semiconductor cycle volatility and competitive pressures from Synopsys. Upside potential exists if the company maintains its earnings beat streak and capitalizes on AI infrastructure spending.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →